Literature DB >> 18303853

Dihydrobenzo[c]phenanthridine alkaloids from stem bark of Zanthoxylum nitidum.

Cheng-Hui Yang1, Ming-Jen Cheng, Michael Y Chiang, Yueh-Hsiung Kuo, Chyi-Jia Wang, Ih-Sheng Chen.   

Abstract

Five novel alkaloids, zanthomuurolanine ( 1), epi-zanthomuurolanine ( 2), zanthocadinanines A ( 3) and B ( 4), and epi-zanthocadinanine B ( 5), composed of dihydrochelerythrine and a cadinane-type sesquiterpene linked by a methylene bridge, have been isolated from stem bark of Zanthoxylum nitidum. These structures were elucidated by spectroscopic techniques (UV, IR, MS, CD, 1H NMR, 13C NMR, DEPT, COSY, NOESY, HSQC, and HMBC analyses). Single-crystal X-ray diffraction studies confirmed the relative configurations of 1 and 4 and provided additional support for the structures of 2, 3, and 5.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303853     DOI: 10.1021/np700745f

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Evaluation of Zanthoxylum armatum Roxb for in vitro biological activities.

Authors:  Fiaz Alam; Qazi Najam Us Saqib
Journal:  J Tradit Complement Med       Date:  2017-02-14

2.  Profiling and Pharmacokinetic Studies of Alkaloids in Rats After Oral Administration of Zanthoxylum nitidum Decoction by UPLC-Q-TOF-MS/MS and HPLC-MS/MS.

Authors:  Aihua Huang; Yuguang Chi; Jiawei Liu; Mincun Wang; Jialiang Qin; Lijuan Ou; Weiwen Chen; Zhongxiang Zhao; Ruoting Zhan; Hui Xu
Journal:  Molecules       Date:  2019-02-07       Impact factor: 4.411

3.  Complete chloroplast genome sequence of Zanthoxylum nitidum (Rutaceae), an important medicinal shrub.

Authors:  Yancai Shi; Rong Zou; Bingbing Liu
Journal:  Mitochondrial DNA B Resour       Date:  2019-11-12       Impact factor: 0.658

4.  Spectrum-Effect Relationship Analysis of Bioactive Compounds in Zanthoxylum nitidum (Roxb.) DC. by Ultra-High Performance Liquid Chromatography Mass Spectrometry Coupled With Comprehensive Filtering Approaches.

Authors:  Si-Wei Rao; Yuan-Yuan Duan; Han-Qing Pang; Shao-Hua Xu; Shou-Qian Hu; Ke-Guang Cheng; Dong Liang; Wei Shi
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.